Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00128284 · ClinicalTrials.gov registry record
A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time
A clinical trial of Gastroparesis and Gastrointestinal Diseases, sponsored by The SmartPill Corporation.
- Completed
- Registry status
- 148
- Enrollment target
- 7
- Study locations
NCT00128284: Completed study of Gastroparesis and Gastrointestinal Diseases, sponsored by The SmartPill Corporation.
NCT00128284 is a study of Gastroparesis and Gastrointestinal Diseases that has completed, run by The SmartPill Corporation. The registered enrollment target is 148 participants, below the 299-participant average among 44 other Gastroparesis trials with a reported enrollment target (51% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00128284, a study of Gastroparesis and Gastrointestinal Diseases, has completed, sponsored by The SmartPill Corporation.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to determine the correlation between gastric residence time of the SmartPill Capsule and the time required for partial emptying of a standard radiolabeled meal as measured by gastric emptying scintigraphy.
Conditions Studied
Study Locations (7)
Kansas
- Division of Gastroenterology and Hepatology at KUMC - Kansas City
Kentucky
- University of Louisville Medical Center - Louisville
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- University of Michigan Medical Center - Ann Arbor
New York
- VA Medical Center - Buffalo
North Carolina
- Wake Forest University Baptist Medical Center - Winston-Salem
Pennsylvania
- Temple University Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2005-02 |
| Est. Completion | 2005-10 |
What the finished NCT00128284 record still lists
NCT00128284 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 299-participant average among 44 other Gastroparesis trials with a reported enrollment target (51% lower).
The record links to 3 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.
NCT00128284 lists 7 locations in 7 states (Kansas, Kentucky, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00128284 about?
NCT00128284 is a clinical study titled "A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time". The purpose of this study is to determine the correlation between gastric residence time of the SmartPill Capsule and the time required for partial emptying of a standard radiolabeled meal as measured by gastric emptying scintigraphy.
What is the current status of trial NCT00128284?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2005-02. Estimated completion is 2005-10.
What conditions does trial NCT00128284 study?
This clinical trial studies the following conditions: Gastroparesis, Gastrointestinal Diseases, Stomach Diseases.
Who is sponsoring clinical trial NCT00128284?
This trial is sponsored by The SmartPill Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00128284 being conducted?
This trial has 7 study locations across Kansas, Kentucky, Massachusetts, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00128284's enrollment target sits among peer trials
148 16th of 44 higher than 29 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia